Top Markets
#1 Ontology Gas Ontology Gas +46.81%
#2 Verus Coin Verus Coin +22.52%
#3 EXOD EXOD +22.08%
#4 Fake World Assets Fake World Assets +22.08%
#5 ETHGas ETHGas +21.14%
#6 Status Status +17.96%
#7 Geodnet Geodnet +17.50%
#8 The Black Bull The Black Bull +16.80%
#9 Derive Derive +11.99%
#10 Ontology Ontology +11.87%
Coin of the day
Ontology Gas Ontology Gas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Classifica tra le azioni #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Prezzo delle azioni
$1.34
Ultima sincronizzazione: 2024-02-14
Capitalizzazione di mercato
$48.96M
Variazione (1 giorno)
-12.94%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Promore Pharma AB (publ) (PROMO)

Categoria

Healthcare
Rapporto P/B per Promore Pharma AB (publ) (PROMO)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Promore Pharma AB (publ), il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Promore Pharma AB (publ) da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US